Anúncio
Anúncio
REVB
Revelation Biosciences, Inc. Common Stock
0.90
USDPatrocinado
0.00
-0.25%
08 de jan., 15:59 UTC -5
Encerrado
Pré-Mercado
0.89
-0.01
-1.02%
Relatórios de Lucros REVB
Rácio de surpresa positiva
REVB separação 10 de 15 últimas estimativas.
67%
Próximo Relatório
Data do Próximo Relatório
04 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/-$0.93
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/-47.46%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/-93.78%
Revelation Biosciences, Inc. Common Stock earnings per share and revenue
On 06 de nov. de 2025, REVB reported earnings of -1.77 USD per share (EPS) for Q3 25, missing the estimate of -1.36 USD, resulting in a -29.98% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a -2.91% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 4 analistas forecast an EPS of -0.93 USD, with revenue projected to reach -- USD, implying an diminuir of -47.46% EPS, and aumentar of 0.00% in Revenue from the last quarter.
FAQ
What were Revelation Biosciences, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Revelation Biosciences, Inc. Common Stock reported EPS of -$1.77, missing estimates by -29.98%, and revenue of $0.00, 0% as expectations.
How did the market react to Revelation Biosciences, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -2.91%, changed from $1.01 before the earnings release to $0.98 the day after.
When is Revelation Biosciences, Inc. Common Stock expected to report next?
The next earning report is scheduled for 04 de mar. de 2026.
What are the forecasts for Revelation Biosciences, Inc. Common Stock's next earnings report?
Based on 4
analistas, Revelation Biosciences, Inc. Common Stock is expected to report EPS of -$0.93 and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio